News

Roche and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and…
Read More...

The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for adult patients with active…
Read More...

Inflazome, the pioneering inflammasome biotech company developing multiple drugs that stop harmful inflammation, today announces that it has been granted Orphan Drug Designation by the…
Read More...

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely…
Read More...

Rocket Pharmaceuticals, Inc. announces that the first patient has received investigational therapy in the open-label, Phase 1 clinical trial of RP-L301, the Company’s lentiviral vector…
Read More...

Ovid Therapeutics Inc. and Angelini Pharma S.p.A. announced an agreement in which Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 (gaboxadol) for the…
Read More...

Revitope Oncology Inc. and Junshi Biosciences announced the companies have entered into a strategic research collaboration. Revitope will leverage its proprietary protein engineering…
Read More...

Merus N.V. and Caris Life Sciences announced a collaboration to detect neuregulin 1 (NRG1) fusions in cancer patients. Under the agreement, Caris has agreed to perform whole exome…
Read More...

Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being…
Read More...

Roche announced results from the second interim analysis of the phase IIIb STASEY study, which reinforce the safety profile of Hemlibra (emicizumab) characterised in the phase III HAVEN…
Read More...

Roche announced that the Phase III IMagyn050 study showed that the addition of Tecentriq (atezolizumab) to Avastin (bevacizumab), paclitaxel and carboplatin did not meet its primary…
Read More...

Amgen announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership of…
Read More...

The Therapeutic Goods Administration (TGA) has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19. It has…
Read More...

ProteinQure announces a collaboration with the global biopharmaceutical company AstraZeneca to apply structure-based design to the creation of therapeutic libraries with the aim of…
Read More...

Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Hulio (adalimumab-fkjp), a biosimilar to AbbVie's Humira …
Read More...

Kymera Therapeutics Inc. announced the company has entered into a multi-program strategic collaboration with Sanofi to develop and commercialize first-in-class protein degrader…
Read More...

Moderna, Inc. and Laboratorios Farmacéuticos Rovi, S.A. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA vaccine candidate against…
Read More...

Pfizer Inc. announced it has pledged $100 million to the new Antimicrobial Resistance (AMR) Action Fund, which launched today, to help address the significant global public health need…
Read More...

Boehringer Ingelheim and Numab Therapeutics (Numab) announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects…
Read More...